市場調査レポート

商品コード

1569490

免疫診断の市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Immunodiagnostics Market Size, Share, Growth Analysis, By Product (Instruments, Reagents & Consumables), By Application (Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals), By Region - Industry Forecast 2024-2031

出版日: 2024年10月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

免疫診断の世界市場規模は、2022年に232億米ドルと評価され、2023年の241億7,000万米ドルから2031年には336億米ドルに達し、予測期間中（2024年～2031年）のCAGRで4.20％の成長が予測されています。

世界の免疫診断市場は、複数の主要要因によって力強い成長が見込まれています。免疫診断は、幅広い疾患の診断とモニタリングに免疫ベースのアッセイを採用しており、感染症、自己免疫疾患、がんの罹患率の増加が、正確で効率的な診断ソリューションの需要を大幅に押し上げています。酵素結合免疫吸着測定法（ELISA）、化学発光免疫測定法（CLIA）、迅速診断検査を含むイムノアッセイの技術的進歩は、感度と特異性を著しく向上させ、市場拡大に寄与しています。さらに、病気の早期発見の重要性に対する意識の高まりと個別化医療の人気の高まりが、免疫診断ツールの需要を刺激し続けています。その結果、米国の免疫診断市場は今後1年間、持続的なCAGRを維持すると予測されています。この動向は、健康課題に効果的に対処し、患者の転帰を改善するために、革新的な診断手法への依存度が高まっていることを浮き彫りにしています。全体として、技術革新と意識の高まりの融合により、免疫診断分野はヘルスケアの展望において実質的な進歩を遂げるものと位置づけられています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Abbott（US）
Roche Diagnostics（Switzerland）
DiaSorin（Italy）
Danaher Corporation（US）
QIAGEN（Netherlands）
bioMerieux（France）
Thermo Fisher Scientific（US）
Quest Diagnostics（US）
Siemens Healthineers AG（Germany）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Mindray Medical International Limited（China）
Grifols, S.A.（Spain）
Becton, Dickinson and Company（BD）（US）
Abcam plc（UK）
Merck KGaA（Germany）
Enzo Biochem, Inc.（US）
Bio-Techne Corporation（US）
Meso Scale Diagnostics, LLC.（US）
GenScript Biotech Corporation（China）
Myriad Genetics, Inc.（US）

Product Code: SQMIG35A2401

Global Immunodiagnostics Market size was valued at USD 23.2 billion in 2022 and is poised to grow from USD 24.17 billion in 2023 to USD 33.6 billion by 2031, growing at a CAGR of 4.20% during the forecast period (2024-2031).

The global immunodiagnostics market is poised for robust growth, driven by multiple key factors. Immunodiagnostics involves employing immune-based assays to diagnose and monitor a wide array of diseases, and the increasing incidence of infectious diseases, autoimmune disorders, and cancer is significantly boosting the demand for precise and efficient diagnostic solutions. Technological advancements in immunoassay methodologies, including enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), and rapid diagnostic tests, have notably enhanced sensitivity and specificity, thereby contributing to market expansion. Furthermore, a growing awareness regarding the importance of early disease detection, coupled with the rising popularity of personalized medicine, continues to stimulate demand for immunodiagnostic tools. As a result, the U.S. immunodiagnostics market is anticipated to maintain a sustainable compound annual growth rate (CAGR) in the upcoming forecast year. This trend highlights the increasing reliance on innovative diagnostic methods to effectively address health challenges and improve patient outcomes. Overall, the convergence of technological innovations and heightened awareness positions the immunodiagnostics sector for substantial progression in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global immunodiagnostics Market Segmental Analysis

Global Immunodiagnostics Market is segmented by Product, Application, End user, and region. Based on Product, the market is segmented into Instruments, and Reagents & Consumables. Based on Application, the market is segmented into Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, and Others. Based on End user, the market is segmented into Clinical Laboratories, Hospitals, Physician's Offices, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global immunodiagnostics Market

The increasing emphasis on early disease detection is driving the global immunodiagnostics market, as healthcare providers recognize that timely intervention can significantly enhance treatment outcomes and lower overall healthcare expenses. Immunodiagnostics play a pivotal role by enabling the identification of specific biomarkers and molecular targets, which in turn supports early diagnosis and the development of personalized treatment strategies tailored to individual patient profiles. This shift towards precision medicine not only fosters more effective clinical decisions but also promotes patient-centered care, thereby propelling demand for immunodiagnostic solutions across various healthcare settings and ultimately reinforcing market growth.

Restraints in the global immunodiagnostics Market

One of the primary market restraints for the global immunodiagnostics market is the high cost associated with the acquisition and maintenance of diagnostic equipment and reagents. These financial burdens can hinder the adoption of immunodiagnostic tests, particularly in resource-limited settings where healthcare budgets are constrained. As hospitals and clinics in developing regions grapple with limited funding and competing healthcare priorities, the significant investment required for immunodiagnostic technologies may deter facilities from implementing these advanced diagnostic solutions. Consequently, this pricing challenge can impede the overall growth and accessibility of immunodiagnostics, ultimately affecting patient care and outcomes in underserved populations.

Market Trends of the global immunodiagnostics Market

In recent years, the global immunodiagnostics market has witnessed a significant trend towards the integration of digital health solutions driven by technological advancements and an increased demand for efficient healthcare delivery. This shift encompasses the adoption of online platforms for testing, mobile applications for result tracking, and telehealth services that facilitate remote consultations and monitoring. As patients and providers leverage wearables and remote diagnostic tools, the immunodiagnostics sector is increasingly characterized by real-time data sharing, streamlined workflows, and enhanced patient engagement. This trend is expected to bolster market growth, reflecting a larger movement towards personalized and accessible healthcare solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Immunodiagnostics Market by Product

Market Overview
Instruments
Reagents & Consumables

Immunodiagnostics Market by Application

Market Overview
Oncology & Endocrinology
Hepatitis & Retrovirus
Cardiac Markers
Infectious Diseases
Others

Immunodiagnostics Market by End user

Market Overview
Clinical Laboratories
Hospitals
Physician's Offices
Online Pharmacies

Immunodiagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics, LLC. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

免疫診断の市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024-2031年

Immunodiagnostics Market Size, Share, Growth Analysis, By Product (Instruments, Reagents & Consumables), By Application (Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

免疫診断市場：製品別

免疫診断市場：用途別

免疫診断市場：エンドユーザー別

免疫診断市場規模：地域別